1. Home
  2. OSBC vs LBRX Comparison

OSBC vs LBRX Comparison

Compare OSBC & LBRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Old Second Bancorp Inc.

OSBC

Old Second Bancorp Inc.

HOLD

Current Price

$24.97

Market Cap

1.3B

Sector

Finance

ML Signal

HOLD

Logo LB Pharmaceuticals Inc

LBRX

LB Pharmaceuticals Inc

HOLD

Current Price

$42.93

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OSBC
LBRX
Founded
1981
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.5B
IPO Year
2014
2025

Fundamental Metrics

Financial Performance
Metric
OSBC
LBRX
Price
$24.97
$42.93
Analyst Decision
Buy
Strong Buy
Analyst Count
4
5
Target Price
$23.50
$46.60
AVG Volume (30 Days)
377.8K
238.3K
Earning Date
04-22-2026
05-06-2026
Dividend Yield
1.36%
N/A
EPS Growth
N/A
98.22
EPS
1.02
N/A
Revenue
N/A
N/A
Revenue This Year
$25.20
N/A
Revenue Next Year
$3.66
N/A
P/E Ratio
$24.45
N/A
Revenue Growth
N/A
N/A
52 Week Low
$16.65
$13.40
52 Week High
$26.06
$50.16

Technical Indicators

Market Signals
Indicator
OSBC
LBRX
Relative Strength Index (RSI) 44.33 43.01
Support Level $24.93 $22.85
Resistance Level $25.95 $49.74
Average True Range (ATR) 0.48 2.06
MACD -0.10 -0.95
Stochastic Oscillator 33.96 17.85

Price Performance

Historical Comparison
OSBC
LBRX

About OSBC Old Second Bancorp Inc.

Old Second Bancorp Inc is a bank holding company. It provides consumer and commercial banking products such as demand, money market, savings, time deposit, and individual retirement as well as commercial, industrial, consumer, and real estate lending, including installment loans, student loans, agricultural loans, lines of credit and overdraft checking, safe deposit operations, trust services, wealth management services, and additional services tailored to the needs of individual customers, corporates, small-medium enterprises. The company has one operating segment, which is community banking. The company's revenue consists of interest, commission, payments, and other income.

About LBRX LB Pharmaceuticals Inc

LB Pharmaceuticals Inc is a late-stage biopharmaceutical company developing novel therapies for the treatment of a wide range of neuropsychiatric disorders including schizophrenia, bipolar depression, adjunctive treatment of depressive disorder and other diseases. It is building a pipeline that leverages the broad therapeutic potential of its product candidate, LB-102, which it believes has the potential to be the first benzamide antipsychotic drug approved for neuropsychiatric disorders in the United States. LB-102 is currently in late-stage clinical development for schizophrenia and bipolar depression. The company operates as a single reportable segment in the development of novel therapies for the treatment of neuropsychiatric diseases, including schizophrenia.

Share on Social Networks: